Grant: Discovery Grants Program - Individual
University of British Columbia
$15,000.00
Statistical design and analysis methodology for clinical trials
FY 2011-12
Summary
My research in the recent past has concentrated in three general areas:
1. Statistical design and analysis methodology for clinical trials.
2. Environmental epidemiological studies of the effects of air pollution on human health, where the primary focus is on subject-area issues but open methodological issues relating to the most appropriate designs and most effective methods of statistical analysis for such studies naturally arise.
3. Development of sequential designs for clinical experiments within a decision-theoretic framework, where the aim is to determine optimal designs and investigate the performance of competing designs.
My activity over the current funding period evolved to become concentrated in the first area and I expect this to continue during the next funding period. This research is motivated by my collaboration with the MS/MRI Research Group at UBC and my involvement with organizations such as the U.S. National MS Society that are concerned with improving how clinical trials in MS are carried out and analyzed. The focus of the research is to develop suitable stochastic models for the types of longitudinal data collected in clinical trials in MS, to determine effective designs for clinical trials in MS and to determine efficient methods of analyzing the types of data collected in clinical trials in MS. (These stochastic models, experimental designs and methods of statistical analysis are also relevant in many other areas, but my primary involvement is in MS.) This research involves investigating the suitability of available statistical methodology for the MS context and developing new statistical methodology to address problems arising the the MS context. The overall objective is to enhance the amount of information obtained from clinical trials in MS, through the development of more effective designs and more comprehensive approaches to the analysis of the data collected.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
4586-2009
Name nom
Petkau, John
Department département
Statistics
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
15000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
14
Committee name en
Statistical Sciences
Committee name fr
Statistique
Area of application code
1205
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Mathematical sciences
Area of application fr
Sciences mathématiques
Research subject code
3004
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Applied statistics
Research subject fr
Statistique appliquée
Partie
3
Nb partie
5
Application title
Statistical design and analysis methodology for clinical trials
Keyword
NSERC
Application summary
My research in the recent past has concentrated in three general areas:
1. Statistical design and analysis methodology for clinical trials.
2. Environmental epidemiological studies of the effects of air pollution on human health, where the primary focus is on subject-area issues but open methodological issues relating to the most appropriate designs and most effective methods of statistical analysis for such studies naturally arise.
3. Development of sequential designs for clinical experiments within a decision-theoretic framework, where the aim is to determine optimal designs and investigate the performance of competing designs.
My activity over the current funding period evolved to become concentrated in the first area and I expect this to continue during the next funding period. This research is motivated by my collaboration with the MS/MRI Research Group at UBC and my involvement with organizations such as the U.S. National MS Society that are concerned with improving how clinical trials in MS are carried out and analyzed. The focus of the research is to develop suitable stochastic models for the types of longitudinal data collected in clinical trials in MS, to determine effective designs for clinical trials in MS and to determine efficient methods of analyzing the types of data collected in clinical trials in MS. (These stochastic models, experimental designs and methods of statistical analysis are also relevant in many other areas, but my primary involvement is in MS.) This research involves investigating the suitability of available statistical methodology for the MS context and developing new statistical methodology to address problems arising the the MS context. The overall objective is to enhance the amount of information obtained from clinical trials in MS, through the development of more effective designs and more comprehensive approaches to the analysis of the data collected.